Reddit Posts
OTLK down 80% discounted shares. glta
OTLK - Excellent Investment Opportunity
$OTLK - Outlook Therapeutics® Announces Validation of Marketing Authorization Application by the European Medicines Agency for ONS-5010 as a Treatment for Wet AMD
OTLK - Trenary C Russell III + Dagnon Terry they Bought OTLK Shares on June 21, 2022 (INSIDERS BUY)
OTLK - Bullish Outlook Therapeutics, Inc. (NASDAQ:OTLK) insiders filled their treasuries with US$557k worth of stock over last year
OTLK - Bullish Outlook Therapeutics, Inc. (NASDAQ:OTLK) insiders filled their treasuries with US$557k worth of stock over last year
OTLK - Bullish Outlook Therapeutics, Inc. (NASDAQ:OTLK) insiders filled their treasuries with US$557k worth of stock over last yea
OTLK - Interview about confidence in the FDA approval process for BLA
OTLK - JASON HOPE SEC SCHEDULE 13G Number of shares Beneficially Owned on March 18, 2022
OTLK - Outlook Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for ONS-5010 as a Treatment for Wet AMD.
November gainers - top 5 tickers with the highest insiders *buying* activity
November gainers - top tickers with the highest insiders *buying* activity
OTLK - Target Price (in 12 months) +277% to +403%
OTLK - Target Price (in 12 months) +277% to +403%
More Penny Stocks Getting Bought By Insiders - $SELB $OTLK $XOS $PED $HCDI
OTLK - ZACKS give again a BUY recommendations.
Outlook Therapeutics (NASDAQ:OTLK) Lifted to "BUY" at Zacks Investment Research Posted by Joseph Griffin on Aug 26th, 2021
Outlook Therapeutics (NASDAQ:OTLK) Lifted to "BUY" at Zacks Investment Research Posted by Joseph Griffin on Aug 26th, 2021
Outlook Therapeutics (NASDAQ:OTLK) Lifted to "BUY" at Zacks Investment Research Posted by Joseph Griffin on Aug 26th, 2021
Outlook Therapeutics Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update.
OTLK - Corporate Presentation - August 10, 2021
OTLK 🚀BBIG 🚀VERB 💎there going to the moon
OTLK Price Target Raise to $8,00 (Brookline Capital Markets)
OTLK Positive Efficacy Data on Phase 3 NORSE TWOO
OTLK Potential Buyout above $50 with this Phase 3 Great News
OTLK Today Reports Positive Efficacy and Safety Data from Pivotal Phase 3 NORSE TWO Trial of ONS-5010 / LYTENAVA™
OTLK Today Reports Positive Efficacy and Safety Data from Pivotal Phase 3 NORSE TWO Trial of ONS-5010 / LYTENAVA™
Outlook therapeutics(OTLK) report positive efficacy data from Phase 3. Plans to commercialize their product in a $13 billion market
APE Premarket! 08/03 $WHLM $TBIO $OTLK $AUTO $HOLI
APE Premarket! 08/03 $WHLM $TBIO $OTLK $AUTO $HOLI
OTLK Very solid sign for Phase 3 results announcement in Q3 2021
$OTLK Buy and Hold. "BIG PROFITS" on the way!
$OTLK Buy and Hold. "BIG PROFITS" on the way!
$OTLK Chartmill "Outlook Therapeutics Inc is a setup today!"
Interview with C. Russell Trenary III OTLK President and Chief Executive Officer
Interview with C. Russell Trenary III OTLK President and Chief Executive Officer
Something to consider for your portfolios
OTLK-Outlook Therapeutics Appoints C. Russell Trenary III as President and Chief Executive Officer Expert Executive on BLA and M&A
OTLK Outlook Therapeutics is now on Russell 2000® and 3000® Indices.
OTLK Outlook Therapeutics is now on Russell 2000® and 3000® Indices.
OTLK Outlook Therapeutics is now on Russell 2000® and 3000® Indices.
$OTLK Outlook Therapeutics is now on Russell 2000® and 3000® Indices.
OTLK – In June 25, 2021 after market close will be add to Russel 2.000 Index
OTLK will be added to Russell 3000 in JUNE 2021
OTLK - will be added to Russell 3000 in JUNE 2021
OTLK Will Be a Billion Dollar a Year Biotech
BB and the silent assassin OTLK
$OTLK - Outlook Therapeutics - Potential $50 Buyout by EOY/2022 - PT Q3/Q4 2021 is $8 to $12 --- PT Q1/Q2 2022 is $30 to $50 buyout.
$OTLK - Outlook Therapeutics - $50 Buyout Potential EOY, or 2022 - PT Q3/Q4 2021 $8 to $12 -- PT Q1/Q2 2022 $30 to $50
$OTLK Keep Buying and Holding for BIG PROFITS with the next 3 catalyst events:
$OTLK Keep Buying and Holding for BIG PROFITS with the next 3 catalyst events:
OTLK Next 3 big catalyst events for BIG PROFITS
Mentions
Of course it is. Small-cap Biotech is a complete gamble. If the stock market is a casino, Biotech is the nude russian roulette taking place in the fucking basement. It’s bang or bust. They will never be priced in relation to fwd expectations because of the significant amount of risk and uncertainty. OTLK, PSTV, CRMD, NBP, are all good examples. The market is loaded with these kind of bets. I think it’s fun, threw couple of thousands to either be pleasantly surprised, or expectedly disappointed.
OTLK to the moon don’t sleep
Anyone on OTLK? Volume looks great
OTLK is dope, I dont hold it but i have a few 1.50$ calls for january 2027. What do you think of ASBP aspire biopharma, to me that one feels like OTLK, IOBT and INTS
Meant to say OTLK crashed from 3$ to 0.8$ not 0.8 cents whoopsie
My top 3 penny stocks back in June were NEHC(which is now NUAI and had bought 10k shares for 0.47 and sold them at 0.55 to get in the IXHL craze, which flopped and NEHC went to become NUAI and look at it now) IXHL which i mentioned, and CGTX(this one went from 60c to over 3$, currently 1.65). Getting into BioPharma stocks (ixhl&cgtx) is what opened the gate for me to be more curious about more, which is how i ended falling into INTS after it crashed, i thought it was a great opportunity. I also bought 20k shares of OTLK after it crashed from 3$ to 0.8 cents, currently 1.24 which is cool 🤩 I’m currently bagholding IXHL & PSTV & BTOG & BNKK, I can get profits from INTS & OTLK anytime I guess. P.S. BNKK was SHOT before, could be a bad stock pick, but my gut feeling made me do it. All of this is NOT financial advice, just my personal adventure
OTLK was the same. It has less side-affects and safer option and the only competition was an off-brand med that was meant for something else. And FDA rejected it even though EU had accepted.
I would try really hard to avoid biomedical stocks like IXHL, SHOT, FEMY, or RVPH. Or you would have to be very diligent and proactive in getting out as well as you can when you are at the top. Biomedical stocks usually drop very fast whenever something positive happens as everyone wants to “buy the rumor, sell on the news”, so usually there’s not very stable long term gains on biomedical stocks aside from the big names like NVO or LLY or PFE. Quite a few of us have learned the lesson the hard way with things like OTLK or MBOT or FBIO. Once the catalyst happens, biomedical stocks usually drop and takes a long time to recover again since it takes a lot of effort and capital for a biomedical stock to actually advertise and produce the said development
Jeeze, got 5 SEC form 4 filings e-mail alerts from OTLK in the last hour. Wonder what's going on with them Also two form 4 filings from PSTV
https://preview.redd.it/2criaa5h8asf1.png?width=361&format=png&auto=webp&s=84fea4aff45573420173b1615c881cba3c5e9c15 Spotted a pre-market MACD jumping unicorn dolphin on OTLK. That can't be bad.
What’s going on with OTLK
This was me with OTLK a week ago
What do you guys think of VSC and OTLK?
OTLK is a mystery to me. I’ve been in and out, trying to find a good entry point. It seems like it should go up once it has clarity from the FDA, but if the outcome of their upcoming meeting is bad (like, rerun the trial) then I expect it’d tank further. Still, with the trial success they’ve had and their ability to gain authorization in other countries, it’s a little weird that they’re having such issues and it seems like they should be able to get it over the line soon
Was lucky with $TAWNF - Thai Airways went bankrupt and was holding shares, when they relisted again they are doing great $OTLK - Dropped down after they got a letter from FDA, now waiting on FDA approval, will blow up
$UP - wheels up Experience Inc - leading brand in private aviation. Currently 2.37$ with delta air lines being one of their top investors. $OTLK - outlook therapeutics - biopharmaceutical company. Currently **0.89** $. Its main product Lytenava - used for macular degeneration - and recently the FDA denied the application in its present form BUT it is approved in Europe since May 2024 and it is used in USA as off -label made in the pharmacies and its price is way cheaper than Lucentis (competitor owned by Roche). So it just need time to get more studies and now it's way too cheap not to buy.
Had the same thoughts when I saw the comparison to OTLK bevavizumab. Wet AMD already had other treatments available but Menkes doesn't. Therefore, you either give something knowing the alternative is literally nothing and earlier mortality
I don't think it will. The initial data was unsatisfactory even if the final phase seem to be more like a success. What we saw with OTLK can be seen here unless they have some soft power :)
https://preview.redd.it/ngtyzi5oqrlf1.jpeg?width=1206&format=pjpg&auto=webp&s=d98e11f154208c7a58e050693e5bc48d48b767cc OTLK - easier play, nobody listen
Scoop bottom if you really did the DD, this is my 2nd scoop the bottom from OTLK. They got the CRL early this year and I scooped the bottom reversal play hehehe
OTLK - who bought when I posted? Say thank you to me!!
Why is OTLK spiking, it hit the kitty litter with FDA today
OTLK went flaccid. Even Viagra wouldn't pump this thing
> ISELIN, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) to its biologics license application (BLA) resubmission, indicating that the FDA **cannot approve** the application in its present form for the treatment of wet age-related macular degeneration (wet AMD). The stock is crashing. Is this good news?
OTLK - why you didn’t listen? Scoop the bottom! Now 0.8x !! I posted it was between 0.6-0.7x
Thank god I dumped OTLK last night
OTLK - my prediction was correct ! 2nd CRL! Anyway scoop some bottom, should recover >1.2
Watching **$TELO** PM 35% AH Telomir-1’s *emerging profile as a potential first-in-class epigenetic therapy* : https://www.sec.gov/ix?doc=/Archives/edgar/data/0001971532/000164117225025688/form8-k.htm Entered AH **$OTLK** -20% on a day **PDUFA LYTENAVA** (Aug 27), waiting for news. **(High risk)** Both didn’t really have any hype or serious run ups. NFA
OTLK may be a high risk-high reward play, word on FDA approval should arrive by the end of the day and the stock is dipping
🚀 OTLK – FDA Decision Tomorrow (Aug 27th) – Mega Risk / Mega Reward 🚀 Outlook Therapeutics ($OTLK) is waiting on the FDA decision for ONS-5010 (Lytenava) to treat wet AMD. Already approved in EU/UK ✅ US market = BILLIONS 💰 FDA PDUFA date = Aug 27th 🗓️ This is the definition of a lotto biotech play: Approval → could gap up +100%+ overnight 📈 Tiny market cap. Massive catalyst. High risk, high reward. Only put in what you’re willing to lose. 🎲
BTAI and OTLK full all in.
last time to get into OTLK 24 hours for fda approval
OTLK looking interesting. FDA approval decision due tomorrow...\~$130m market cap, targeting a \~$10B market Already approved (May 2024) and selling the same drug in Europe.
OTLK fast money move tomorrow through Friday.
OTLK no doubt about it. LFG!
OTLK can show some movement given anticipated FDA approval on aug 27
OTLK crossed $3.00 in AH in advance of the August 27 PDUFA goal date
OTLK has a PDUFA date on 25-08-27. Its not a submission.
Thoughts on OTLK hold over the weekend?
What do yall think about OTLK? I just bought some lol
OTLK sure looks like it's going to rip soon
OTLK waiting on FDA approval sometime next week. Just something I'm keeping an eye on.
Bought OTLK, see DD in main sub
Bought into OTLK yesterday after visiting the FDA calendar. Thanks for the DD
So I figure anything not vaccine-related is getting rubber stamp approval from the FDA now that the worm guy has fully crippled HHS. I'm getting some lottery tickets for smaller companies with pending approvals over the next 1-2 months. ARWR, OTLK, TNXP. Lets see if any print.
Aren't you interested in OTLK? I think I'm the only one interested...
OTLK FDA approval August 27 No more dilution, royalty based fundraising 2 catalysts prior to FDA approval Outlook Therapeutics (OTLK) is a clinical-stage biotech developing ONS‑5010 (LYTENAVA™), a bevacizumab-based treatment for wet AMD. The drug is already commercially launched in the UK and Germany, with a key FDA decision (PDUFA date) set for August 27, 2025. The company recently raised $13M (May 2025) and had ~$7.6M cash as of March 31, 2025, but is burning cash quickly (Q2 net loss: $46.4M). Despite financial risk, OTLK is partnered with Cencora for global distribution and is targeting major expansion in Europe and Asia. Analyst sentiment is bullish, with average price targets of $8.50–$9.60 and highs near $21, implying 300%+ upside from the ~$2.04 current share price. Insider ownership is strong (~37%), and the float is relatively low, increasing volatility and squeeze potential. This is a high-risk, high-reward play hinging on the FDA’s upcoming decision — a potential breakout or breakdown event. FDA approval for Outlook Therapeutics’ ONS‑5010 appears highly likely, as the company has already resolved prior manufacturing issues, secured EU/UK approvals, and the FDA has accepted the resubmitted Biologics License Application without raising new questions ahead of the August 27, 2025 decision date — all strong signals of regulatory confidence.
OTLK potential FDA approval for Lytenava and first earnings in Europe.
Thoughts on OTLK for August?
Instructions unclear, buying Outlook Therapeutics (OTLK).
OTLK with biotech stock with a patent held up by nonsense it’s 1 dollar now it will be 10 dollars next year look at estimates
I’m green in ACHR, GRRR, HYSR. Red in OTLK, CABA. ACHR & GRRR hopefully going to the moon. 🚀
I’m a n00b. I’m green on ACHR, GRRR, HYSR. Red on CABA, OTLK.
You mentioned having OTLK a few months ago. How do you feel about it now? Do you think those price targets ($9 low, $100 high) are reasonable?
Bruh OTLK is done.. just do a google search may be.:
OTLK. +100% by December +300% by June.
I like eyeballs. I am having a blast with ALDX. Their dry eye disease drug Reproxalap and partnership with ABBV is good stuff. I also suggest looking into OCUL. I am currently just following Wet Age Macular Degeneration market... OTLK is trying...
You can see more information about OTLK on Reddit "OTLK_Investors".
First off institutional ownership doesn’t guarantee anything. Also OTLK’s issue appears to be with manufacturing, which ironically was the problem it was trying to solve. Also you tell me https://www.formosapharma.com/app13007/
Just curious why you think EYEN will be approved when OTLK wasn't. Not trying to be an ass just curious because neither has much institutional ownership.
You still in EYEN? I got burned by OTLK so I'm being extra cautious with DD.
OTLK 
OTLK doing good today. In ICU, as well
$OTLK i think it can test the 1$ today
OTLK 
OTLK and LXRX. Both have had large insider stock purchases very recently. OTLK dropped from $1.40 upon denial by FDA to .23 overnight. Then insiders grabbed up over 2 million shares. It’s had a steady 5 day climb since.
Is this going to be one of those days? Almost everything on my watchlist, whether I'm holding any shares or just watching, is red. Ah well, not much to do but keep holding and watching my money disappear in T2, AXLA, NVOS (I stupidly bought in at its peak, as I seem to always do with this stock), EZGO, ASCX, INPX, and OTLK.
Forgot NVOS and OTLK could pop back up again
OTLK on the hopes that they have some good news to announce at the H.C. Wainwright Global Investors Conference at 09:30 Eastern Time today that causes them to climb back up.
Thinking about OTLK (Outlook Therapeutics). It recently tanked from $1.40 to \~$0.20 due to the FDA declining to approve their drug for treating Age-Related Matricular Degeneration, an eye disease. They got declined due to some sort of manufacturing concerns, it seems? From [this Reuters article](https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-outlook-therapeutics-eye-disease-drug-2023-08-30/): "Outlook Therapeutics said on Wednesday that although the trial for the drug met the goals of safety and efficacy, the FDA cited the need for further confirmatory clinical evidence." It's been staying in the low 0.20s since then. They have a presentation tomorrow morning at the H.C. Wainwright Global Investment Conference. No idea what they are going to present, but if it is something that increases investor confidence or shows a good chance of overcoming the FDA concerns and getting approval, we might see the price climb back up. Thoughts? Anyone heard any other news?
Old adage: run your runners shoot the losers. Set from this new price a stop loss if you are determined to hodl…the prospects look a lot better than some of the other small cap Pharma such as OTLK
OTLK and ARAV I'm watching tomorrow
I have also OTLK big loss i am keeping and buying the dip and you?
Latest analyst report on OTLK from BTIG -- [https://smallpdf.com/result#r=1fdb571ced832676cdee112daad0f9fb&t=share-document](https://smallpdf.com/result#r=1fdb571ced832676cdee112daad0f9fb&t=share-document)
every loss is a lesson - down $20k with OTLK today, still up over all but it happens - I treat it as an expensive hobby 😂
OTLK (outlook therapeutics) @ $0.21813 buy at the bottom. I’m guessing they’re not going to get delisted because of this, so back up over $1.00 in the next 210 days. We’ll see :-)
OTLK down to 30 cents after FDA put them on hold. buy the dip?
Did OTLK get FDA approval?
Pay attention to OTLK. There's a possible FDA approval today.